Circulating tumor DNA predicts prognosis at different time points in patients with esophageal cancer: a systematic review and meta-analysis
{{output}}
Background: Circulating tumor DNA (ctDNA), as a liquid biopsy biomarker, is undergoing extensive evaluation for its clinical utility across multiple tumor management scenarios. This study aimed to assess the prognostic value of c... ...
